A Cochrane review¹⁰⁹ identified ten randomised controlled trials of pharmacological treatments for obese children.

Most of these trials had small sample sizes (range 24-539 participants,  with 60%  including fewer…

We recommend that children with BMI higher than the 95th percentile, or higher than the 85th percentile when accompanied   by   comorbidities,  such   as   hypertension, hyperlipidaemia, or impaired glucose…

Prevention,  especially in young people,  is universally viewed as the best approach to reverse the rising global prevalence of obesity. However, evidence about the most effective means of prevention of obesity development in…

Endocrine   diseases,  congenital   and   acquired   hypothalamic defects,  genetic syndromes,  and use of drugs affecting   appetite   should   be   considered   during assessment of…